APCR Issues Statement on COVID-19

Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

CureVac’s German Owner Rejects US Coronavirus Vaccine Grab

Mon, 03/16/2020 - 1:26am

Dietmar Hopp, 80% shareholder of German mRNA company CureVac, has rejected the possibility that the company would sign an exclusive...

      Related Stories 

AnGes Takes DNA Vaccine Tack As It Enters Virus R&D Fray

Sun, 03/15/2020 - 9:45pm

Japanese bioventure goes down the DNA vaccine route, along with several others worldwide, pointing to potential development speed and safety...

      Related Stories 

Lynparza/Recentin Combo Fails In Phase III PSR Ovarian Cancer

Sun, 03/15/2020 - 12:50pm

Lynparza will weather the failure of the Phase III GY004 study, but VEGF inhibitor Recentin’s future looks even less certain;...

      Related Stories 

Deal Watch: Lilly, AbCellera Partner To Attempt Rapid COVID-19 Vaccine Development

Fri, 03/13/2020 - 12:49pm

Partnership will combine AbCellera’s screening of antibodies to the virus with Lilly’s development, commercial capabilities. Vir adds Biogen tie-up to...

      Related Stories 

Repertoire Launches To Turn Immune System Insights Into T-Cell Therapies, Vaccines

Fri, 03/13/2020 - 11:22am

Flagship Pioneering combined Torque Therapeutics and Cogen Immune Medicines, which have raised more than $220m, into Repertoire Immune Medicines with...

      Related Stories 

Pipeline Watch: Approvals In Cushing's Syndrome, Hepatocellular Cancer

Fri, 03/13/2020 - 9:32am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies...

      Related Stories 

All Aboard The Biotech Train: AstraZeneca Campus Gets Connected

Fri, 03/13/2020 - 8:15am

The new Cambridge South station should be ready by 2025, serving AstraZeneca’s new HQ and leading hospitals and research institutes.

      Related Stories 

Buyers And Sellers: How Corporate Transactions Are Shaping Pharma

Fri, 03/13/2020 - 6:56am

Infographic: Scrip homes in on key figures for companies integrating major acquisitions or divesting significant parts of their business.  

      Related Stories 

Dainippon Lays Out R&D Table Ahead Of Latuda Challenges

Thu, 03/12/2020 - 10:01pm

Vant deal, discovery platforms help Japanese firm build out pipeline before it faces the first expiries for its top seller.

      Related Stories 

McKinsey Execs On Expanding Pharma’s Digital Push, Lessons From Amazon

Thu, 03/12/2020 - 4:37pm

Two McKinsey & Company executives share their views on pharma’s digital trajectory, including the role of manufacturing ‘lighthouses’ and opportunities...

      Related Stories 

UK Experimental AMR Payment Program “On Track”

Thu, 03/12/2020 - 9:23am

Designers of the UK’s experimental antibiotic payment system aim to identify two drugs later this year which will then undergo...

      Related Stories